ImmunityBio, Inc. · 1 week ago
Sales Training and Development Director
United States
Full-time
Remote
Director/Executive
$177K/yr - $194K/yr
8+ years expImmunityBio, Inc. is a commercial-stage biotechnology company focused on developing innovative therapies to enhance the immune system's ability to combat cancer and infectious diseases. The Sales Training & Development Director will lead the training and development efforts for the Commercial Operations team, ensuring effective training frameworks and curricula to enhance sales productivity and efficiency.
Health CareHealth DiagnosticsTherapeutics
Responsibilities
Implement a clear framework of training goals and tactics to develop a best-in-class Field Sales Operations organization for on-boarding, initial sales training and advanced/on-going training and development
Develop training curricula, state-of-the-art training tools, materials and related skills development programs to meet launch and brand training needs
Ensure an efficient and effective process for delivering training
Monitor the effectiveness of existing training and evaluate curricula and programs to determine overall effectiveness
Conduct regular training needs assessment activities, proposing and developing solutions to fill training gaps
Define and track KPIs for training effectiveness
Utilize sales data, assessments, and feedback to refine content, methods, and programs
Collaborate with analytics and brand team members to ensure training supports targeting, incentive plans and commercial priorities
Partner with HR on onboarding logistics and performance management objectives
Foster a learning environment based on adult learning principles that ensures optimal comprehension, development and retention
Create, edit and adhere to Standard Operating Procedures (SOPs), process improvements, and standardization of templates as needed
Performs ad-hoc and cross-functional duties and/or projects as assigned to support business needs and provide developmental opportunities
Qualification
Required
Bachelor's degree in business, science or related field required
8+ years of learning and development experience working in the pharmaceutical or biotech industry required
Experience in learning principles and application, curriculum development and instructional design required
Experience with in-person and virtual training models including instructor-led, virtual instructor-led, virtual and web-based training required
Demonstrated ability to originate a creative and innovative approach to sales training needs, using latest technology and approaches to adult learning
Excellent persuasive written and verbal communication skills
Excellent presentation (platform) skills
Ability to effectively work in groups, prepare and give relevant, targeted presentations to large and small audiences
Ability to adjust to changing needs within the organization and flexibility to change priorities as needed
Ability to self-direct projects and work with little supervision
Preferred
A master's degree (MBA) is preferred
Pharmaceutical launch experience with the ability to create a supporting sales training framework preferred
Experience in urology and/or oncology preferred
Prior sales management/leadership experience preferred
Benefits
Medical, Dental and Vision Plan Options
Health and Financial Wellness Programs
Employer Assistance Program (EAP)
Company Paid and Voluntary Life/AD&D, Short-Term and Long-Term Disability
Healthcare and Dependent Care Flexible Spending Accounts
401(k) Retirement Plan with Company Match
529 Education Savings Program
Voluntary Legal Services, Identity Theft Protection, Pet Insurance and Employee Discounts, Rewards and Perks
Paid Time Off (PTO) includes: 11 Holidays
Exempt Employees are eligible for Unlimited PTO
Non-Exempt Employees are eligible for 10 Vacation Days, 56 Hours of Health Pay, 2 Personal Days and 1 Cultural Day
Company
ImmunityBio, Inc.
ImmunityBio, Inc.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.36BKey Investors
Oberland CapitalNantCapitalPatrick Soon-Shiong
2025-07-25Post Ipo Equity· $80M
2025-04-08Post Ipo Equity· $75M
2024-12-11Post Ipo Equity· $100M
Leadership Team
Enrique Diloné
Chief Technology Officer
Leonard Sender
COO
Recent News
Genetic Engineering News
2026-01-23
legacy.thefly.com
2026-01-23
Company data provided by crunchbase